Senior insider sale
Chief Executive Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$432.3K
52.29K shares
What this filing means
BARROW ROBERT plans to sell 52.29K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $432.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/25/2025ACC: 0001950047-25-007516
DirectorOfficer· Chief Executive Officer
Since Jan 2022
52.29K
Shares to sell
$432.3K
Approx. market value
25.80K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
9/25/2025
25.80KTotal acquired25.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/25/2025 | Restricted stock vesting under a registered plan Not Applicable | 25.80K | — |
| Total | 25.80K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
26.49K
Market value
$180.2K
6/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
25.80K
Market value
$252.1K
9/25/2025
Total
Units
52.29K
Value
$432.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2025 | 26.49K | $180.2K | — | Completed |
| Planned — Approximate Date | ||||
9/25/2025 | 25.80K | $252.1K | NASDAQ | Planned |
| Total | 52.29K | $432.3K | ||